Johnson & Johnson Stock Outlook: Is Wall Street Bullish or Bearish?

New Brunswick, New Jersey-based Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various products in the healthcare field. Valued at a market cap of $366.3 billion, the company operates through pharmaceuticals, medical devices, and consumer products divisions.

This healthcare giant’s shares have significantly lagged behind the broader market over the past 52 weeks. JNJ has declined 3% over this time frame, while the broader S&P 500 Index ($SPX) has gained 20.9%. Nevertheless, the stock is up 5% on a YTD basis, compared to SPX’s 1.9% rise during the same time frame.